Sentence examples for interrogating expression from inspiring English sources

Differentially expressed transcripts found in 3D-cultures, human primary cells or clinical samples are useful resources for generation of customized assays interrogating expression of disease relevant genes only.

Positive values indicate an increase in methylation with GDM * p < 0.05 In separate experiments, we assessed differential expression associated with GDM by interrogating expression levels across the genome in a subsample of 55 placentas assessed for genome-wide methylation changes using the Affymetrix Human Transcriptome Array 2.0.

Users can also upload their list of HGNC HUGOO (The Human Genome Organisation) Gene Nomenclature Committee) symbols for interrogating expression patterns.

In theory, if the "target" species for which the array was designed and a "non-target" species are closely related, some probes on the array should be able to interrogate expression of genes in both species without bias if the sequences that are interrogated by the probes are still the same in both species [11] [13].

To interrogate expression levels we calculated FPKM using the published tool Cufflinks.

The Affymetrix Human Genome U133A 2.0 array is a single array used to interrogate expression of 14,500 well-characterized human genes.

A custom microarray chip was utilized to interrogate expression levels of 9,267 lncRNAs in the course of differentiation.

Using amplified messenger RNA and a custom microarray platform designed to interrogate expression for 40,430 genes, we determined global patterns of expression during fibre development.

Some pathway approaches methods use the literature and publicly available annotations (Gene Ontology) to develop gene sets and use these gene sets to interrogate expression data [ 43, 44].

The Affymetrix GeneChip Mouse Genome 430 2.0 arrays, which are designed to interrogate expression of over 39,000 mouse gene transcripts, were used for the hybridization.

Interrogating TIMELESS expression using the GOBO database revealed similar results: increased TIMELESS expression was associated with lower DMFS rate not only in the general breast tumor population (P < 0.005), but also in tumor subtypes, including lymph node-negative (P < 0.001), ER-positive (P < 0.001), and lymph node- negative ER-positive (P < 0.001) breast tumors.